As an example, besides IMPDH2 (previously discussed), impaired de novo biogenesis of pyrimidines through inhibition of DHODH (dihydroorotate dehydrogenase) downregulates rRNA synthesis and triggers IRBC in glioma cells [186]. Here, IMPDH2 is linked to central nervous system cancer.